BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37016465)

  • 1. A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
    Xu F; Peng L; Feng J; Zhu X; Pan Y; Hu Y; Gao X; Ma Y; He Y
    Cancer Imaging; 2023 Apr; 23(1):34. PubMed ID: 37016465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
    Minamitake A; Murakami R; Shiraishi S; Yoshida R; Sakata J; Hirosue A; Kawahara K; Yamana K; Nakayama H; Kitajima M; Sakamoto F
    Oral Radiol; 2022 Jul; 38(3):438-442. PubMed ID: 35088222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study.
    Kaida H; Kitajima K; Sekine T; Ito K; Daisaki H; Kimura T; Sato MP; Enomoto A; Otsuki N; Ishii K
    Dentomaxillofac Radiol; 2023 Oct; 52(7):20230083. PubMed ID: 37494001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
    Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S
    Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative
    Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of SUV
    Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E
    Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour
    Bae MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3341-3348. PubMed ID: 32642973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
    Yamakawa N; Nakayama Y; Ueda N; Yagyuu T; Tamaki S; Kirita T
    Oral Radiol; 2023 Oct; 39(4):668-682. PubMed ID: 37081306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum Standardized Uptake Value (SUV
    Morand GB; Vital DG; Kudura K; Werner J; Stoeckli SJ; Huber GF; Huellner MW
    Sci Rep; 2018 Aug; 8(1):11817. PubMed ID: 30087375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
    Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
    Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.
    Stack BC; Duan F; Subramaniam RM; Romanoff J; Sicks JD; Bartel T; Chen C; Lowe VJ
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1230-1239. PubMed ID: 33231504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.
    Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT
    Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
    Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K
    Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
    Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
    JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma.
    Fukuhara R; Shinya T; Fukuma S; Ogawa N; Masaoka Y; Tanaka T; Marunaka H; Arioka T; Hiraki T; Kaji M; Kanazawa S
    Acta Med Okayama; 2020 Apr; 74(2):123-128. PubMed ID: 32341586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.